Jason Lettmann - 26 Jan 2026 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Reporting relationship
CHIEF EXECUTIVE OFFICER, Director
Issuer ticker
ALXO
Reported as of
26 Jan 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Jan 2026, 16:30:02 UTC
Prior SEC filing
16 Oct 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shelly Pinto, by power of attorney

Key filing fact

Jason Lettmann filed Form 4 for ALX ONCOLOGY HOLDINGS INC (ALXO) on 28 Jan 2026.

Key facts

  • This page summarizes Jason Lettmann's Form 4 filing for ALX ONCOLOGY HOLDINGS INC (ALXO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 28 Jan 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 16 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001688269 Primary reporting owner

Lettmann Jason

Relationship
CHIEF EXECUTIVE OFFICER, Director
Address
C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Signature
/s/ Shelly Pinto, by power of attorney
Signature date
28 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALXO transaction Derivative

Stock option (right to buy)

Award

Transaction value
$0
Shares
+912,000
Change %
Price
$0.000000
Shares after
912,000
Date
26 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
912,000
Exercise price
$1.48
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .